Showing results (561-570 of 611) with videos related to

Sort By:
Pageof 62
JAMA Pediatrics|September 6, 2017
Association of Serum Soluble Urokinase Receptor Levels With Progression of Kidney Disease in ChildrenFranz Schaefer, Howard Trachtman, Elke Wühl, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 30, 2022
Definition, diagnosis and clinical management of non-obstructive kidney dysplasia: a consensus statement by the ERKNet Working Group on Kidney MalformationsStefan Kohl, Fred E Avni, Peter Boor, et al.
BMC Nephrology|April 18, 2015
Rationale, design and objectives of ARegPKD, a European ARPKD registry studyKathrin Ebner, Markus Feldkoetter, Gema Ariceta, et al.
Pediatric Nephrology (Berlin, Germany)|October 31, 2022
Outcomes of steroid-resistant nephrotic syndrome in children not treated with intensified immunosuppressionAgnes Trautmann, Svenja Seide, Beata S Lipska-Ziętkiewicz, et al.
Kidney International|January 10, 2014
Genotype-phenotype associations in WT1 glomerulopathyBeata S Lipska, Bruno Ranchin, Paraskevas Iatropoulos, et al.
Kidney International Reports|October 27, 2025
Efficacy of Calcineurin Inhibition in Children With Steroid-Resistant Nephrotic SyndromeAgnes Trautmann, Jonas Hofstetter, Beata Lipska-Ziętkiewicz, et al.
Kidney International|December 23, 2023
Post-transplant recurrence of focal segmental glomerular sclerosis: consensus statementsRupesh Raina, Swathi Jothi, Dieter Haffner, et al.
Pediatric Nephrology (Berlin, Germany)|January 23, 2025
Survey of legislative frameworks and national recommendations governing paediatric maintenance haemodialysis in EuropeEnzo Vedrine, Claus Peter Schmitt, Johan Vande Walle, et al.
Kidney International|July 22, 2017
Metabolic acidosis is common and associates with disease progression in children with chronic kidney diseaseJérôme Harambat, Kevin Kunzmann, Karolis Azukaitis, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 8, 2022
An update on the use of tolvaptan for autosomal dominant polycystic kidney disease: consensus statement on behalf of the ERA Working Group on Inherited Kidney Disorders, the European Rare Kidney Disease Reference Network and Polycystic Kidney Disease InternationalRoman-Ulrich Müller, A Lianne Messchendorp, Henrik Birn, et al.
Pageof 62